Serum Transthyretin Monomer as a Possible Marker of Blood-to-CSF Barrier Disruption

This work was supported in part by the National Institutes of Health (NIH-NS43284, NIH-HL51614, and NIH-NS38195). We also thank Dr. Anne-Charlotte Aronsson for continuous support and encouragement, and Luca Cucullo, Matteo Marroni, and Barbara Aumayr for helpful discussion. Sangtec Medical (Bromma, Sweden) provided the kits for immunodetection of NSE and S-100β.

Correspondence should be addressed to Dr. Damir Janigro, Cerebrovascular Research, NB-20 Lerner Research Institute, Cleveland Clinic Foundation, 9600 Euclid Avenue, Cleveland, OH 44196. E-mail:janigrd{at}ccf.org.